CCR5 and gastric cancer: In a mouse model of gastric cancer, inhibition of Cysteine-Cysteine Motif chemokine receptor 5 (CCR5) mediated PMN-MDSC accumulation enhances efficacy of anti-PD-1 antibody therapy potentially through reversal of T-cell exhaustion [41,42].